SCHEMBL6799198

SCHEMBL6799198

COc1ccc2c(c1)C(O)CCO2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.48
MAP3K14 Q99558 2/20 0.47
HTR1A P08908 7/20 0.47
HTR2B P41595 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
HTR7 P34969 1/20 0.47
TMEM97 Q5BJF2 1/20 0.47
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31371845 0.87 MAP3K14 (0.59) ENPP2MAP3K14HTR1ADRD2DRD3
SCHEMBL11861133 0.83 HCRTR1 (0.47) HTR1AHTR2BSIGMAR1HTR7TMEM97
SCHEMBL25659961 0.82 ENPP2 (0.49) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL10613752 0.82 ENPP2 (0.47) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL10613891 0.82 ENPP2 (0.47) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL10613885 0.82 ENPP2 (0.47) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL10613749 0.82 ENPP2 (0.47) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL10613757 0.82 ENPP2 (0.47) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL24915967 0.81 ENPP2 (0.46) ENPP2HTR1AHTR2BSIGMAR1HTR7
SCHEMBL24915659 0.81 ENPP2 (0.46) ENPP2HTR1AHTR2BSIGMAR1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6750243-B1 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis AstraZeneća AB (SE) 2004-06-15 US claimed
EP-0278603-B1 CONDENSED PYRAZOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION FARMITALIA CARLO ERBA S.r.l. (IT) 1992-12-02 EP disclosed
US-4853405-A Condensed pyrazole derivatives, pharmaceutical compositions and use FARMITALIA CARLO ERBA S.R.L. (IT) 1989-08-01 US disclosed
US-4777168-A ANTISECRETORY, ANTIULCER AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1988-10-11 US disclosed
EP-0278603-A1 Condensed pyrazole derivatives and process for their preparation FARMITALIA CARLO ERBA S.r.l. (IT) 1988-08-17 EP disclosed
US-4722925-A ANTIULCER AGENTS, GASTROINTESTINAL DISORDERS RORER PHARMACEUTICAL CORPORATION (US) 1988-02-02 US disclosed
EP-0198918-A4 BICYCLIC BENZO-OXY HETEROCYCLIC ETHERS AND THIOETHERS AS H 2?-RECEPTORS ANTAGONISTS. RORER INTERNAT OVERSEAS INC (US) 1987-08-10 EP disclosed
US-4668673-A ANTISECRETORY, ANTIULCER, ANTACIDS WILLIAM H. RORER, INC. (US) 1987-05-26 US disclosed
EP-0198918-A1 BICYCLIC BENZO-OXY HETEROCYCLIC ETHERS AND THIOETHERS AS H 2?-RECEPTORS ANTAGONISTS RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1986-10-29 EP disclosed
US-4612309-A Antisecretory bicyclic benzo-oxy heterocyclic ethers and thioethers WILLIAM H. RORER, INC. (US) 1986-09-16 US disclosed
WO-1986002550-A1 BICYCLIC BENZO-OXY HETEROCYCLIC ETHERS AND THIOETHERS AS H2-RECEPTORS ANTAGONISTS RORER INTERNATIONAL (OVERSEAS) INC. (US) 1986-05-09 WO disclosed